HopeStage
Back to all studies
Not recruitingISRCTN75768415

Pharmacological treatment of Depression: Phase II Lithium addition

Research studyAges 18–65Netherlands
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
Netherlands

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Erasmus Medical Center (The Netherlands)
Sponsor type
Hospital / academic medical center
Study type
Other
Intervention type
Other / unclear
Locations
Netherlands
Age range
From 18 Years to 65 Years
Official registry ID
ISRCTN75768415
Official title
Show the full official title

Pharmacological treatment of Depression: Phase II Lithium addition

Recruitment & locations

Not recruiting

Netherlands

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Erasmus Medical Center (The Netherlands), a hospital or academic medical center.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies